New Treatment Concept

The Problem:  In 2018, it is expected that over 620,000 Americans will die of cancer. Cancer is the second most common cause of death in the US after heart disease….+Learn More

DfuseRxSM

We are pioneering a new approach to treat solid tumor cancers. Our Company’s treatment addresses both the regional and systemic aspects of cancer. The Company’s DfuseRxSM platform technology can rapidly…+Learn More

In Vivo Results

Our products show potent anticancer effectiveness in challenging mouse tumor types.  Animals having a complete response become immunized against the cancer. Using mouse models of severe, late-stage pancreatic, breast, melanoma and…+Learn More

Back to Top